Alamar Biosciences, Inc. (ALMR)

Every figure this model derived for ALMR, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 4,242,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 250,052,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 331,382,000 AssetsCurrent 2026-06-30
current liabilities 27,960,000 LiabilitiesCurrent 2026-06-30
equity 312,857,000 StockholdersEquity 2026-06-30
interest expense 303,000 InterestPaidNet 2026-06-30
ocf -31,669,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 55,462,000 RevenueFromContractWithCustomerIncludingAssessedTax 2026-06-30
sbc 4,747,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up ALMR on one particular measure came for.

RatioValue
cash operating margin-33.95
current ratio12.86
current ratio reported11.85
fcf margin-64.75
interest cover-85.41
operating margin-46.66
owner earnings margin-73.31
revenue growth89.59
revenue growth per share89.59
rule of 4042.93
sbc pct revenue8.56

What to be careful about

What this model itself distrusts about ALMR's figures. Written by the derivation as it ran, not added afterwards.